Hirsutism in Jordanian Women

    January 2023 in “ Scholars journal of applied medical sciences ”
    Amaal Aldubis, Rema Alomoush, Ruba Alsqour, Manar Abu Karake, Mohammed Alkilani, Majeda Alsukar, Rami Alshwayait
    Image of study
    TLDR The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.
    The study investigated the causes and characteristics of hirsutism in 120 Jordanian women with an average age of 24 years. Using the modified Ferriman-Gallwey index, it was found that 50% of the participants had a score above 12, indicating significant hair growth, particularly on the face. More than half of the women experienced menstrual irregularities, and 38.3% were classified as obese. A family history of hirsutism was noted in 45.8% of the cases. The majority of hirsutism cases were attributed to polycystic ovary syndrome (PCOS), which was diagnosed in 56.8% of the women, while 37.5% had idiopathic hirsutism. Other identified causes included microadenoma and hypothyroidism. The study concluded that PCOS and idiopathic hirsutism are the predominant causes of hirsutism in this population.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 25 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 3 weeks ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 10 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    1 / 1 results